Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Blood|August 1, 1996
Tumor necrosis factor-alpha induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptorT van der Poll, P M Jansen, K J Van Zee, et al.
The Journal of Experimental Medicine|March 17, 1997
Epinephrine exerts anticoagulant effects during human endotoxemiaT van der Poll, M Levi, M Dentener, et al.
Critical Care Medicine|June 2, 2000
Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemiaS R Grobmyer, P S Barie, C F Nathan, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 1, 1994
Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsisS E Calvano, W A Thompson, M N Marra, et al.
The Journal of Infectious Diseases|August 1, 1995
Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsisT van der Poll, E Fischer, S M Coyle, et al.
Blood|May 15, 1997
Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humansT van der Poll, S M Coyle, M Levi, et al.
The Journal of Experimental Medicine|July 1, 1996
A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboonM B Welborn, K Van Zee, P D Edwards, et al.
Critical Care Medicine|July 1, 1997
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator GroupS M Opal, C J Fisher, J F Dhainaut, et al.
Pageof 17